Colitis-Associated Cancer May One Day Be Treated With Multiple Sclerosis Drug

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer (CAC). The study, published online in the journal Cancer Cell, was led by Sarah Spiegel, Ph.D., Mann T. and Sara D...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Colorectal Cancer Source Type: news